| For: | Xin Q, Sun Q, Zhang CS, Zhang Q, Li CJ. Functions and mechanisms of chemokine receptor 7 in tumors of the digestive system. World J Clin Cases 2020; 8(12): 2448-2463 [PMID: 32607322 DOI: 10.12998/wjcc.v8.i12.2448] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v8/i12/2448.htm |
| Number | Citing Articles |
| 1 |
Na Young Kim, Yejin Hong, Seung Ho Baek, Dongwoo Nam, Ducdat Le, Mina Lee, Jae-Young Um, Kwang Seok Ahn. Norisoboldine suppresses epithelial–mesenchymal transition in colorectal cancer by simultaneously inhibiting the CXCR4/CXCR7 chemokine receptors and the JAK/STAT3 signaling pathway. Journal of Pharmacy and Pharmacology 2026; 78(7) doi: 10.1093/jpp/rgag071
|
| 2 |
Shiyue Sun, Muhammad Arif Aslam, Eun Bi Ma, Gahui Lee, Hafiz Muhammad Ahmad Javaid, Somy Yoon, Joo Young Huh. Activation of CXCR7 exerts an inhibitory effect on adipogenesis through regulation of β-arrestin2/Wnt and AKT signalling. Adipocyte 2025; 14(1) doi: 10.1080/21623945.2025.2490258
|
| 3 |
Michela Roberto, Giulia Arrivi, Mattia Alberto Di Civita, Giacomo Barchiesi, Emanuela Pilozzi, Paolo Marchetti, Daniele Santini, Federica Mazzuca, Silverio Tomao. The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1154581
|
| 4 |
Liangrui Shi, Yan Huang, Lian Li, Huan Li, Xin Li, Zenghao Bi, Junke Liu, Sanyin Zhang, Zhaotong Cong, Bojun Wang, Shilin Chen. Identification of Entacapone as a Novel β-Arrestin 1 Biased Antagonist of CXCR7. Molecules 2026; 31(15) doi: 10.3390/molecules31152606
|
| 5 |
Tripti Khare, Marc Bissonnette, Sharad Khare. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies. International Journal of Molecular Sciences 2021; 22(14) doi: 10.3390/ijms22147371
|